Fiserv
FISV
$55.88
-1.31%
Fiserv is a leading provider of core account processing and complementary technology services — electronic funds transfer, card issuer processing, loan processing, and merchant acquiring — primarily to US banks, credit unions, and merchants, with roughly 10% of revenue generated internationally. Since its transformative 2019 merger with First Data, Fiserv has positioned itself as a scaled, end-to-end payments and fintech infrastructure platform serving both financial institutions and merchants, competing with FIS, Jack Henry, Global Payments, and Adyen across a broad footprint. The current investor narrative is dominated by a contested turnaround: an abrupt CEO departure in June 2026 amid activist investor pressure, a massive $6.45 billion goodwill impairment tied to margin compression, and persistent revenue declines have collided with aggressive cost-cutting, debt payback, and buyback initiatives that bulls argue can re-accelerate earnings. The stock's violent November rally following a Q3 earnings beat — despite a headline GAAP loss — captures the debate between investors betting on a Q4 inflection and those skeptical that structural margin erosion in merchant acquiring is being papered over by financial engineering.…
FISV
Fiserv
$55.88
Related headlines
Investment Opinion: Should I buy FISV Today?
Rating: Hold. Fiserv is a deep-value turnaround bet whose cheapness (7.10x forward PE, 7.27x EV/EBITDA, 6.06x price-to-free-cash-flow, 1.73x PS) is real but so is the deterioration it discounts — revenue down 1.27% YoY, gross margin down roughly 880bps to 53.06%, and a consensus 'hold' with a 2.78 recommendation mean and a $64.74 average target implying only about +14.3% upside. The core thesis is that the $6.45 billion impairment and cost cuts are cleaning the slate for a Q4 revenue inflection, but the evidence for that inflection is not yet in hand, so the risk-reward is balanced rather than compelling.
Supporting evidence cuts both ways. On the positive side, the stock trades at a fraction of typical IT-services multiples (peers often 3-5x sales and 12-15x EBITDA), the PEG of 0.60 and 1.42x price-to-book versus historical 3-4x place it at the bottom of its multi-year band, TTM free cash flow of $3.158 billion comfortably covers a $333 million quarterly interest bill, and the company repaid $693 million of debt in Q3 and $1.256 billion in Q2 while buying back stock. On the negative side, revenue has been stuck in a $5.0-$5.5 billion band for multiple quarters, the Processing and Services segment is roughly 81% of revenue ($4.231 billion of $5.196 billion) and is the drag, the current ratio of 1.03 leaves almost no cushion, and the 165% analyst target spread ($40 to $106) with only 7 Buy ratings out of 27 signals weak conviction despite the November 3 earnings beat.
Three risks could invalidate the thesis: a Q4 revenue miss that breaks gross margin below 53%, a new CEO strategic reset that brings additional charges, and further downgrades from the cluster of November Neutral reiterations (Citigroup, Bernstein, Truist, UBS, JP Morgan). This Hold would upgrade to Buy if revenue returns to positive YoY growth and gross margin stabilizes above 55%, or if the stock pulls back toward the $43.87 52-week low while fundamentals hold; it would downgrade to Sell if revenue declines accelerate beyond -2% or gross margin breaks below 53%. On balance the stock is undervalued relative to its own history and peers but fairly-to-appropriately priced given the unresolved turnaround — a value trap until revenue inflects, not a bargain yet.
Sign up to view all
FISV 12-Month Price Forecast
Fiserv is a cheap stock with a broken narrative: the valuation (7.10x forward PE, 6.06x price-to-free-cash-flow) prices in severe pessimism, but revenue down 1.27% YoY and gross margin down roughly 880bps to 53.06% justify much of that discount until proven otherwise. The November 3 earnings beat and 17.35% one-month rally show the market is willing to bet on a Q4 inflection, yet the cluster of Neutral reiterations and the 2.78 recommendation mean show analysts are not yet convinced, and the -6.38% November 19 drop on 9.5 million shares warns the rally is meeting resistance. The base case (55% probability) is a grind toward the $64.74 average target as revenue stabilizes, with a 20% bull case toward $106 if margins recover and a 25% bear case toward $40-$44 if the decline persists. I would upgrade to bullish on evidence of positive revenue growth and gross margin above 55%, and downgrade to bearish if gross margin breaks below 53% or the new CEO announces a costly reset.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Fiserv's 12-month outlook, with a consensus price target around $64.93 and implied upside of +16.2% versus the current price.
Average Target
$64.93
37 analysts
Implied Upside
+16.2%
vs. current price
Analyst Count
37
covering this stock
Price Range
$43 - $106
Analyst target range
Coverage is broad with 27 analysts, but sentiment is decidedly cautious: 7 Buy, 27 Hold, and 3 Sell ratings produce a consensus recommendation of "hold" and a recommendation mean of 2.78 (where 3.0 is a pure hold). The average target price of $64.74 implies roughly +14.3% upside from the current $56.62, a modest premium that reflects analyst reluctance to chase the November rally; the consensus leans neutral-to-bearish, consistent with the recent institutional ratings flow showing a wave of Neutral/Hold reiterations from Citigroup, Bernstein, Truist, Cantor Fitzgerald, TD Cowen, UBS, and JP Morgan in early-to-mid November, punctuated only by Argus upgrading to Buy and Keefe Bruyette maintaining Outperform. The target range is extraordinarily wide — from a low of $40.00 to a high of $106.00, a 165% spread — signaling high uncertainty and weak conviction. The $106 high target assumes successful execution of the turnaround: margin stabilization, cost-cut realization, multiple re-rating toward historical norms, and a Q4 revenue inflection, while the $40 low target prices in continued revenue decline, further margin compression, and skepticism that the impairment marks the bottom. The wide dispersion, combined with the cluster of recent Neutral reiterations and the absence of meaningful upgrades despite the earnings beat, suggests analysts are waiting for tangible evidence of a revenue turnaround before committing; estimated EPS of $13.55 and revenue of $22.19 billion for the forward period imply the Street expects modest stabilization rather than robust growth, keeping the risk-reward balanced rather than compelling.
Bulls vs Bears: FISV Investment Factors
The bear case currently holds the stronger evidence: revenue is declining 1.27% year-over-year, gross margin has collapsed roughly 880 basis points in a year to 53.06%, and the CEO departed abruptly in June amid activist pressure, producing a -36.49% max drawdown and a consensus 'hold' with a 2.78 recommendation mean. The bull case rests almost entirely on valuation — a 7.10x forward PE, 7.27x EV/EBITDA, and 6.06x price-to-free-cash-flow — plus a 17.35% one-month rally and a $64.74 average target implying 14.3% upside, but cheap multiples alone are not a catalyst. The single most important tension is whether the Q3 earnings beat marks a genuine Q4 revenue inflection or whether structural margin erosion in merchant acquiring is being papered over by cost cuts, buybacks, and a non-cash impairment that flatters forward EPS optics. If revenue returns to growth and gross margin stabilizes above 55%, the deep-value thesis re-rates sharply; if the decline persists, the 1.73x PS is a value trap, not a bargain.
Bullish
- Deep value on cash-based multiples: At $56.62, FISV trades at a forward PE of just 7.10x, EV/EBITDA of 7.27x, PS of 1.73x, and price-to-free-cash-flow of 6.06x — a fraction of typical IT services multiples of 3-5x sales and 12-15x EBITDA. The PEG of 0.60 and 1.42x price-to-book (versus historical 3-4x) place the stock at the very bottom of its multi-year valuation band, implying deep pessimism is already priced in.
- Analyst target implies 14% upside: The 27-analyst average target of $64.74 implies roughly +14.3% upside from $56.62, and the high target of $106.00 implies +87% if the turnaround executes. Argus upgraded to Buy and Keefe Bruyette maintained Outperform, showing some conviction that the risk-reward has turned favorable at these depressed levels.
- Sharp momentum reversal off lows: The stock is up 17.35% over the past month versus a 6.92% S&P 500 decline, producing +24.27% relative strength, and is up 7.68% over three months. It has bounced roughly 29% off the $43.87 52-week low, and the November 3 earnings beat catalyzed a move from $51.93 to a $63.90 swing high before the recent pullback.
- Deleveraging and buyback support: Fiserv repaid $693 million of debt in Q3 and $1.256 billion in Q2 while continuing buybacks, and TTM free cash flow of $3.158 billion comfortably covers interest expense of $333 million per quarter. The debt-to-equity of 1.13 is manageable, and ROE of 13.49% shows the underlying business still generates solid returns.
Bearish
- Revenue is stagnant to declining: Q3 2026 revenue of $5.196 billion fell 1.27% year-over-year, continuing sequential softness from $5.292 billion in Q2 2026 and $5.284 billion in Q4 2025. Revenue has been stuck in a $5.0-$5.5 billion band for multiple quarters with no acceleration, directly undermining any growth-premium narrative.
- Gross margin erosion is structural: Gross margin has compressed from 61.8% in Q2 2025 to 58.86% in Q3 2025 to just 53.06% in Q3 2026 — a roughly 880 basis point decline in a year. This signals genuine pricing and mix pressure in merchant acquiring, not a one-time accounting event, and the $6.45 billion impairment merely crystallizes it.
- Governance turmoil and CEO exit: The abrupt June 2026 CEO departure for Truist amid activist investor pressure triggered a brutal selloff and a -36.49% max drawdown. Leadership instability during a margin turnaround raises execution risk, and the wave of Neutral/Hold reiterations from Citigroup, Bernstein, Truist, UBS, and JP Morgan in November shows analysts remain unconvinced.
- Weak consensus and wide target dispersion: Of 27 analysts, only 7 rate Buy versus 27 Hold and 3 Sell, producing a recommendation mean of 2.78 (near a pure hold). The target range of $40 to $106 is a 165% spread, signaling very low conviction, and the absence of meaningful upgrades despite the earnings beat suggests the Street is waiting for tangible revenue inflection.
FISV Technical Analysis
Fiserv is in a recovery phase within a broader downtrend: the stock is down 7.44% over the past year and 13.68% year-to-date, but the current price of $56.62 sits at roughly 48% of its 52-week range of $43.87 to $70.41, having bounced sharply off the September-October lows near $44. The 1-year relative strength of -15.47% versus the S&P 500 confirms persistent underperformance, and the max drawdown of -36.49% underscores how punishing the June CEO-exit selloff was; positioning at mid-range rather than near highs means this is neither a momentum chase nor a falling knife, but a contested base-building setup. Recent momentum is decisively positive and sharply divergent from the longer-term trend: the stock is up 17.35% over the past month and 7.68% over three months, versus a 1-month S&P 500 decline of 6.92%, producing a striking +24.27% relative strength over one month. That divergence — a strong 1-month surge against a negative 1-year trend — signals a potential trend reversal catalyzed by the November 3 earnings beat, though the brutal -6.38% single-day drop on November 19 (from $60.48 to $56.62) on elevated volume of 9.5 million shares warns that the rally is encountering heavy resistance and profit-taking. Key technical levels are clear: support sits at the 52-week low of $43.87, with secondary support around the $45-$46 October consolidation zone, while resistance lies at the $63.90 November swing high and then the $70.41 52-week high; a breakout above $64 would confirm the reversal and open a path toward the highs, whereas a breakdown below $50 would invalidate the recovery and re-test the lows. With a beta unavailable in the data but a demonstrated 36.49% peak-to-trough drawdown, position sizing should assume above-market volatility, and the 6.4% single-session decline argues for waiting for stabilization before adding exposure.
Beta
—
—
Max Drawdown
-36.5%
Largest decline past year
52-Week Range
$44-$70
Price range past year
Annual Return
-6.5%
Cumulative gain past year
| Period | FISV Return | S&P 500 |
|---|---|---|
| 1m | +15.9% | -9.7% |
| 3m | +6.3% | -9.9% |
| 6m | -2.2% | -7.5% |
| 1y | -6.5% | +4.7% |
| ytd | -14.8% | +1.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
FISV Fundamental Analysis
The revenue trajectory is stagnant to slightly declining and represents the core bear case: Q3 2026 revenue of $5.196 billion fell 1.27% year-over-year versus $5.263 billion in Q3 2025, continuing a pattern of sequential softness from $5.292 billion in Q2 2026 and $5.284 billion in Q4 2025. The Processing and Services segment generated $4.231 billion, or roughly 81% of quarterly revenue, and is the primary drag as merchant and processing growth decelerates; the multi-quarter trend shows revenue stuck in a $5.0-$5.5 billion band with no clear acceleration, which undermines the growth-premium narrative and explains why the market has punished the stock despite cost discipline. Profitability has deteriorated dramatically on a GAAP basis: Q3 2026 net income was -$5.941 billion (EPS of -$11.17) driven by a $6.45 billion goodwill impairment and other expenses of $6.35 billion, collapsing operating margin to -105.7% from +27.3% in the year-ago quarter, while gross margin compressed to 53.06% from 58.86% a year earlier. Excluding the impairment, the underlying business remains solidly profitable — Q2 2026 net income was $627 million at an 11.85% net margin and Q1 2026 was $571 million at 11.36% — but the steady erosion of gross margin from 61.8% in Q2 2025 to 53.1% in Q3 2026 signals genuine pricing and mix pressure in merchant acquiring that the impairment merely crystallizes. Balance sheet and cash flow health is adequate but leveraged: debt-to-equity stands at 1.13, the current ratio is a thin 1.03, and TTM free cash flow of $3.158 billion (with Q3 FCF of $530 million against $1.012 billion operating cash flow and $482 million capex) covers interest but leaves limited cushion. ROE of 13.49% on a trailing basis is respectable, and the company has been actively deleveraging — repaying $693 million of debt in Q3 and $1.256 billion in Q2 — while buying back stock, but the reliance on internal cash generation to fund both debt reduction and buybacks means external financing risk remains a live consideration given the 1.13 leverage ratio.
Quarterly Revenue
$5.2B
2026-09
Revenue YoY Growth
-1.3%
YoY Comparison
Gross Margin
53.1%
Latest Quarter
Free Cash Flow
$3.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is FISV Overvalued?
Because trailing GAAP net income is deeply negative (-$5.941 billion in Q3 2026 due to the impairment), the trailing PE of 10.56x is distorted and not the appropriate primary metric; instead, the PS ratio of 1.73x and EV/EBITDA of 7.27x are the more meaningful gauges, supplemented by the forward PE of 7.10x. The enormous gap between the trailing PE of 10.56x and forward PE of 7.10x — a 33% compression — implies the market expects earnings to rebound sharply as impairment charges roll off and cost cuts take hold, with consensus forward EPS of $13.55 against a current price of $56.62. Against the Information Technology Services industry, a PS of 1.73x and EV/EBITDA of 7.27x represent a meaningful discount to typical sector multiples (software and IT services peers often trade at 3-5x sales and 12-15x EBITDA), a discount that reflects the revenue decline, leverage, and governance turmoil rather than any structural inferiority. The PEG ratio of 0.60 and price-to-free-cash-flow of 6.06x suggest the stock is cheap on cash-based measures, but the discount is arguably justified until revenue growth inflects. Historically, Fiserv's PS ratio has collapsed from 24.16x in Q1 2025 and 13.27x in Q3 2025 to just 1.73x today, and its PE has fallen from 36.3x in Q1 2025 to 10.56x — placing the stock at the very bottom of its multi-year valuation band. That extreme compression signals the market is pricing in severe fundamental deterioration and skepticism about the turnaround; it represents either a deep value opportunity if margins stabilize or a value trap if revenue declines persist, and the 1.42x price-to-book versus historical levels of 3-4x reinforces how far sentiment has fallen.
PE
10.6x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 10x~46x
vs. Industry Avg
19.1x
Industry PE ~19.1x*
EV/EBITDA
7.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the deteriorating margin profile and thin liquidity. Gross margin has fallen from 61.8% in Q2 2025 to 53.06% in Q3 2026, and the Q3 GAAP operating margin of -105.7% (versus +27.3% a year earlier) reflects a $6.45 billion goodwill impairment plus $6.35 billion of other expenses. The current ratio of 1.03 leaves virtually no short-term cushion, debt-to-equity of 1.13 means debt payback and buybacks compete for the same cash, and Q3 free cash flow of $530 million against $482 million of capex is thin relative to a $333 million quarterly interest bill. Revenue concentration compounds this: the Processing and Services segment is roughly 81% of quarterly revenue ($4.231 billion of $5.196 billion), so any further deceleration in that single segment hits the whole company. Market and competitive risks stem from the contested turnaround and valuation uncertainty. Fiserv competes with FIS, Jack Henry, Global Payments, and Adyen, and the Zacks note on Global Payments' Worldpay integration driving strong revenue growth and margin expansion highlights a rival executing where Fiserv is contracting. The 165% analyst target spread ($40 to $106) and 2.78 recommendation mean signal weak conviction, and the cluster of November Neutral reiterations from Citigroup, Bernstein, Truist, UBS, and JP Morgan means any Q4 revenue miss could trigger downgrades and multiple compression. With a demonstrated -36.49% max drawdown and a -6.38% single-day drop on 9.5 million shares on November 19, the stock has shown it can gap violently on news, and its -15.47% one-year relative strength versus the S&P 500 confirms persistent underperformance that could invite further sector rotation out of laggards. The worst-case scenario is a chain in which Q4 revenue fails to inflect, gross margin breaks below 53%, the new CEO announces a strategic reset with additional charges, and analysts converge toward the $40 low target. From $56.62, a move to the $43.87 52-week low represents roughly -22.5%, and a slide to the $40 bear-case target implies about -29.3%; a full retest of the -36.49% max drawdown from current levels would put the stock near $36. Given the 1.03 current ratio and 1.13 leverage, a simultaneous credit-rating concern or refinancing at higher rates would amplify the downside beyond the equity's fundamental value.
FAQ
The most severe risk is margin and revenue deterioration: gross margin fell from 61.8% in Q2 2025 to 53.06% in Q3 2026 and revenue declined 1.27% year-over-year, and if that persists the 1.73x PS is a value trap rather than a bargain. Second is balance-sheet and liquidity risk, with a current ratio of just 1.03 and debt-to-equity of 1.13, meaning debt payback and buybacks compete for the same $3.158 billion of TTM free cash flow while $333 million of quarterly interest must be serviced. Third is execution and governance risk from the abrupt June 2026 CEO exit amid activist pressure, which raises the chance the new leader announces a strategic reset with additional charges on top of the $6.45 billion impairment. Fourth is sentiment and competitive risk: only 7 of 27 analysts rate Buy (2.78 recommendation mean), the target range spans $40 to $106, and rivals such as Global Payments are expanding margins through the Worldpay integration while Fiserv contracts — any Q4 miss could trigger the downgrades that compress the multiple further.
The 12-month forecast splits into three scenarios totaling 100% probability. The base case (55%) targets $60-$70, centered on the $64.74 average analyst target, assuming revenue stabilizes near flat, gross margin holds in the low-to-mid 50s, and the $13.55 forward EPS consensus is delivered. The bear case (25%) targets $40-$44, aligned with the $40 low analyst target and the $43.87 52-week low, if Q4 revenue misses, gross margin breaks below 53%, and the new CEO announces a costly reset. The bull case (20%) targets $85-$106, anchored on the $106 high target, if revenue returns to growth, gross margin recovers above 55%, and the multiple re-rates toward historical norms. The base case is most likely because the stock already trades at 7.10x forward earnings and the November 3 earnings beat showed the market will reward stabilization, but the key assumption is that the revenue decline does not accelerate beyond roughly -2%.
On cash-based measures Fiserv screens deeply undervalued: 7.10x forward PE, 7.27x EV/EBITDA, 1.73x sales, 6.06x price-to-free-cash-flow, a PEG of 0.60, and 1.42x price-to-book versus historical levels of 3-4x. The trailing PE of 10.56x is distorted by the $6.45 billion goodwill impairment that drove Q3 GAAP EPS to -$11.17, so the forward multiple is the more meaningful anchor. Against IT-services peers that typically trade at 3-5x sales and 12-15x EBITDA, Fiserv trades at roughly half or less, and its own PS ratio has collapsed from 24.16x in Q1 2025 to 1.73x today. That discount is not irrational — it prices in a 1.27% revenue decline, 1.13 debt-to-equity, and a CEO transition — so the market is paying a discount, not a premium, but the discount is arguably fair until revenue inflects. The verdict is undervalued relative to history and peers, yet appropriately priced for an unresolved turnaround.
The risk/reward is balanced rather than compelling, which is why the synthesized view is Hold rather than Buy. On the reward side, the stock at $56.62 sits 14.3% below the $64.74 average analyst target and 87% below the $106 high target, while trading at 7.10x forward earnings, 7.27x EV/EBITDA, and 6.06x free cash flow — multiples that already embed a lot of bad news. On the risk side, revenue fell 1.27% year-over-year in Q3 2026, gross margin has compressed roughly 880 basis points to 53.06%, and the stock just dropped 6.38% in a single session on 9.5 million shares after failing near $64. The biggest downside is a retest of the $43.87 52-week low, about -22.5%, or roughly -29.3% to the $40 bear-case target if Q4 revenue fails to inflect. It is a reasonable buy only for patient value investors who can tolerate that drawdown and who size the position small; it is not a good buy for momentum traders or anyone needing income, since the dividend yield is 0%.
Fiserv is better suited to a patient, long-term value approach than to short-term trading. It is a mature, low-growth franchise with no dividend (0% yield, 0 payout ratio), so returns must come from earnings stabilization and multiple repair rather than income or rapid compounding, and the 12-24 month turnaround timeline implied by the base case fits a multi-quarter holding period. Short-term traders face elevated event risk: the stock swung from $51.93 to $63.90 and back to $56.62 within three weeks, including a -6.38% single-day drop on 9.5 million shares, and the -36.49% max drawdown shows how violently it can gap on news such as the June CEO exit. A concrete minimum holding period of 12 months is appropriate, giving time for Q4 and subsequent quarters to confirm or refute the revenue inflection. Position sizing should assume above-market volatility given the 165% analyst target spread and the 1.03 current ratio.

